Stories
Prime takes third in the 2020 Best Places to Work in New Mexico
Prime Therapeutics was named an employer of choice, noted for excellent morale, engagement and retention
August 28, 2020Finalist scores were revealed at a virtual awards ceremony on Aug. 20. Winning companies were recognized for creating positive work environments, and for promoting New Mexico and its area employers. Read more about the Best Places to Work winners in the online edition of Albuquerque Business First and more about the survey and selection process here.
Survey comments revealed the coronavirus pandemic and its unique challenges as a common theme this year. Albuquerque Business First noted that more than 70 percent of this year’s finalists said it was important that their company helped them balance working from home with their personal obligations.
When all of Prime moved to become remote in March, Albuquerque employees turned this challenge into an advantage. “Working remotely supports a flexible work-life balance. That has helped keep our staff happy and motivated,” says Dan White, director, operations. “I’m particularly proud that our productivity and quality have continued to improve under the new working conditions,” he adds.
This success contributed to Prime’s decision to permanently move to a remote working environment in Albuquerque. Although the workforce will be more geographically dispersed, Prime’s commitment to Albuquerque will continue. “Even with our employees working from home, we will continue to invest in the community and in local programs important to our employees,” says Maria Schoneman, senior HR business partner.
Prime’s dedicated workforce in Albuquerque – and across Prime – has risen to the challenges presented by the pandemic. “Despite everything we’ve faced this year, winning this award illustrates how connected employees continue to feel to Prime, and to our mission to help people get the medicine they need to feel better and live well,” Dan adds.
Related news
Stories
May 15, 2024
Prime/MRx experts share clinical insights for migraine treatment
Drs. Tracey Garcia and Amy Pappas, board-certified neurologists, reviewed migraine risk factors and treatments in a recent webinar moderated by Dr. Marci Chodroff, vice president of medical affairs
Stories
May 14, 2024
Prime/MRx real-world GLP-1 persistence and adherence data published in Journal of Managed Care & Specialty Pharmacy
Among the key findings from the study — among 4,066 members, Prime/MRx found 1 in 3 stayed on their GLP-1 and 27% took their medication as intended
Stories
May 14, 2024
Prime/MRx releases its first corporate social responsibility report
New report, an evolution of previous DEI reports, aims to demonstrate transparency and accountability for company’s corporate social responsibility journey